Detroit Tigers pitcher Tarik Skubal is scheduled for surgery to remove bone chips from his left elbow.
The loss of the two-time Cy Young winner creates a significant gap in the Tigers' rotation during a critical stretch of the season. Because the American League Central is currently described as "wide-open," the team's ability to maintain its standing depends on the depth of its pitching staff.
Jon Heyman said Skubal is expected to undergo the procedure to address bone chips that were causing irritation. Before the injury, Skubal had been throwing 98 mph [1].
There is currently a discrepancy regarding the timeline for Skubal's return to the mound. The initial belief is that the pitcher could return in about two months [1]. However, a surgeon warned that the injury could potentially sideline Skubal for the remainder of the season [2].
Despite the uncertainty of the recovery period, some analysts believe the team can still find success. Former pitcher CC Sabathia said he remains a believer that Detroit can rebound in the AL Central [3]. Sabathia's outlook suggests that the competitive landscape of the division allows for a recovery even after losing a primary starter.
The Tigers must now navigate the schedule without their ace while awaiting a final determination on Skubal's recovery progress. The team's performance in the coming weeks will determine if Sabathia's optimism regarding the division's volatility is accurate.
“Tarik Skubal is expected to undergo left elbow surgery today.”
The Tigers face a high-risk period where they must prove their rotational depth. While a two-month recovery window would allow Skubal to return for a postseason push, a season-ending diagnosis would force Detroit to rely on secondary options to maintain their position in a volatile AL Central race.
